Baibys has developed an autonomous sperm selection system for in‑vitro fertilization that analyzes living sperm cells in real time using machine vision and artificial intelligence. The platform evaluates cells by high‑magnification morphological criteria and recognizes structures in motion to assess quality. It then autonomously selects and collects sperm with the highest fertilization potential for microinjection into the egg during IVF procedures. The company says the system relies on state‑of‑the‑art AI algorithms to apply previously established selection criteria. Baibys plans to use newly raised capital to expand operations, advance development efforts, and broaden its business reach. The team includes chairman Itay Itzhaky, CEO Dr. Yaron Silberman, co‑founder & co‑CEO Gal Golov, co‑founder & CMO Dr. Nino Guy Cassuto, and senior R&D and regulatory leaders.

Total raised

$5M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2024